Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome

NCT00030550 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG: thalidomide

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]